STOK - Stoke Therapeutics, Inc.
NEXT EARNINGS:
Mar 17, 2026
(in 20 days)
EPS Est: $-0.75
|
Rev Est: $6.4M
Price:
--
--
|
CONSENSUS:
Buy
DETAILS
|
PRICE TARGET:
$42.75
DETAILS
HIGH:
$60.00
LOW:
$35.00
MEDIAN:
$38.00
CONSENSUS:
$42.75
UPSIDE:
20.42%
Market Cap:
2.03B
Volume:
810,457
Avg Volume:
791,018
52 Week Range:
5.35-38.693
Sector:
Healthcare
Industry:
Biotechnology
Beta:
1.11
Last Dividend:
$N/A
Exchange:
NASDAQ
Country:
US
Employees:
128
IPO Date:
2019-06-19
EPS (TTM):
-1.65
P/E Ratio:
-6.69
Revenue (TTM):
36.55M
Total Assets:
271.56M
Total Debt:
2.32M
Cash & Equiv:
127.98M
Rev Growth (5Y):
71.7%
EPS Growth (5Y):
N/A
FCF Growth (5Y):
N/A
ROCE:
-43.8%
Debt/Equity:
0.01
Earnings History
| Date | EPS Actual | EPS Est | EPS Surprise | Rev Actual | Rev Est | Rev Surprise |
|---|---|---|---|---|---|---|
| 2025-11-04 | $-0.65 | $-0.54 | -20.4% | $10.6M | $4.6M | +133.4% |
| 2025-08-12 | $-0.40 | $-0.57 | +29.8% | $13.8M | $5.4M | +158.0% |
| 2025-05-13 | $1.90 | $-0.37 | +613.5% | $158.6M | $31.5M | +403.2% |
| 2025-03-18 | $-0.18 | $-0.51 | +64.7% | $22.6M | $3.9M | +485.9% |
| 2024-11-05 | $-0.47 | $-0.52 | +9.6% | $4.9M | $4.2M | +16.5% |
| 2024-08-07 | $-0.46 | $-0.57 | +19.3% | $4.8M | $3.3M | +48.2% |
| 2024-05-06 | $-0.57 | $-0.60 | +5.0% | $4.2M | $3.2M | +31.3% |
| 2024-03-25 | $-0.60 | $-0.62 | +3.2% | $2.8M | $3.2M | -13.8% |
| Metric | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 36.55M | 8.78M | 12.40M | 0 | 0 | 0 | 0 | 0 |
| Net Income | (88.98M) | (104.70M) | (101.07M) | (85.81M) | (52.24M) | (32.33M) | (12.52M) | (5.56M) |
| EPS | -1.65 | -2.38 | -2.60 | -2.34 | -1.56 | -1.59 | -0.53 | -0.24 |
| Total Assets | 271.56M | 228.34M | 256.07M | 238.87M | 297.93M | 228.75M | 107.54M | 2.44M |
| Total Debt | 2.32M | 2.06M | 2.36M | 1.51M | 1.07M | 0 | 0 | 3.00M |
| Cash & Equivalents | 127.98M | 191.44M | 113.56M | 144.90M | 287.31M | 222.47M | 105.40M | 1.80M |
| Operating Cash Flow | (86.85M) | (81.07M) | (31.87M) | (66.91M) | (42.22M) | (31.05M) | (10.96M) | (5.38M) |
| Free Cash Flow | (87.05M) | (82.68M) | (35.83M) | (68.11M) | (43.27M) | (32.69M) | (11.90M) | (5.50M) |
| FCF per Share | -1.61 | -1.88 | -0.92 | -1.85 | -1.29 | -1.82 | -0.51 | -0.23 |
| Book Value | 229.02M | 159.56M | 184.85M | 217.78M | 286.08M | 224.43M | 105.07M | (1.29M) |
| Cash & ST Investments | 216.90M | 201.39M | 229.59M | 219.81M | 287.31M | 222.47M | 105.40M | 1.80M |
| ROC Equity | -0.39 | -0.66 | -0.55 | -0.39 | -0.18 | -0.14 | -0.12 | N/A |